BiomOrgan proudly announces that our founder, Prof. Zhou Jie, has co-led a landmark study that successfully cultured Human Rhinovirus C (HRV-C) for the first time using a respiratory organoid system. This breakthrough overcomes a decades-long barrier in virology and unlocks new possibilities for antiviral screening and vaccine development. It further reinforces BiomOrgan’s position as Asia-Pacific’s first and a world-leading respiratory organoid platform, advancing translational research and driving therapeutic innovation.

➡️ Read Full Press Release

Partnership Inquiries: bd@biomorgan.hk